Europe Molecular Cytogenetics Market Size & Outlook
Europe molecular cytogenetics market, 2018-2028 (US$M)
Related Markets
Europe molecular cytogenetics market highlights
- The Europe molecular cytogenetics market generated a revenue of USD 410.3 million in 2020.
- The market is expected to grow at a CAGR of 11.5% from 2021 to 2028.
- In terms of segment, oncology was the largest revenue generating application in 2020.
- Personalized Medicine is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2021 to 2028.
Europe data book summary
| Market revenue in 2020 | USD 410.3 million |
| Market revenue in 2028 | USD 981.2 million |
| Growth rate | 11.5% (CAGR from 2020 to 2028) |
| Largest segment | Oncology |
| Fastest growing segment | Personalized Medicine |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Disorders, Oncology, Personalized Medicine, Other Applications |
| Key market players worldwide | Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.9% of the global molecular cytogenetics market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 915.4 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Cytogenetics Market Scope
Molecular Cytogenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe molecular cytogenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 39.61% in 2020. Horizon Databook has segmented the Europe molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.
Europe’s market is significantly backed by the presence of high-tech biopharmaceutical companies, distinct collaborations between research institutes-biotech manufacturers and manufacturer to accelerate innovation, drug development, and platform advancements.
Other factors such as increasing cancer incidence, large number of genetic disorders, initiatives by regulatory agencies in the region are responsible for the molecular cytogenetics advancements. Platforms developed are approved by the European agency and provided CE mark for commercial use of the product or the platform for diagnosis.
These regulations all over the Europe are laid by the European Cytogeneticists Association. In Europe, Germany leads the market in terms of technological sophistication and revenue generation, which is closely followed by the UK and other countries like France, Spain, and others. Increasing cases of genetic and inherited diseases along with early diagnosis of diseases are major factors boosting market growth.
Reasons to subscribe to Europe molecular cytogenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe molecular cytogenetics market databook
-
Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe molecular cytogenetics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe molecular cytogenetics market size, by country, 2018-2028 (US$M)
Europe Molecular Cytogenetics Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
